Direktorat Registrasi ObatValid

DOLUTEGRAVIR/LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE

BPOM Number: GKL2444600517A1
Approved: 24 June 2026
Expiry: 19 May 2031
Form: TABLET SALUT SELAPUT

About This Registration

DOLUTEGRAVIR/LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2444600517A1. Its current registration status is Valid, with the licence valid until 19 May 2031. The product is registered to SAMPHARINDO RETROVIRAL INDONESIA - INDONESIA. BPOM first approved this registration in May 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 30 June 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 1 BOTOL PLASTIK @ 30 TABLET SALUT SELAPUT
Department: Direktorat Registrasi Obat
Data Last Updated: 30 June 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

SAMPHARINDO RETROVIRAL INDONESIA - INDONESIA
KOTA SEMARANG
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

SAMPHARINDO RETROVIRAL INDONESIA - INDONESIA
KOTA SEMARANG
primary
View profile →

Ingredients (6)

DOLUTEGRAVIR SODIUM<DOLUTEGRAVIR SODIUM. LAMIVUDINE. TENOFOVIR DISOPROXIL FUMARATEBR>LAMIVUDINE<BR>TENOFOVIR DISOPROXIL FUMARATE

Market Intelligence

Owner Portfolio: SAMPHARINDO RETROVIRAL INDONESIA - INDONESIA holds 22 BPOM registrations
Manufacturer Scale: SAMPHARINDO RETROVIRAL INDONESIA - INDONESIA produces 22 registered products
Registration Age: Registered for 4 months

FDA Cross-Reference

via openFDA

Generic Name: ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?